CIK 0001710340 · Non-accelerated filer<br>Smaller reporting company
Eton Pharmaceuticals, Inc.
Sign in to watch- Ticker
- ETON
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 371858472
- Phone
- (847) 787-7361
- Business address
- 21925 W. FIELD PARKWAY, SUITE 235, DEER PARK, IL, 60010-7278
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $19,432,082
- in 7 filings
Net −$19,432,082. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-01-12 | Erdogan-Trinkaus Ipek Chief Commercial Officer | Grant or award · Restricted Stock Units | +25,856 | 149,734 | ||
| 2026-01-12 | BRYNJELSEN SEAN President & CEO | Grant or award · Employee Stock Option (Right to Buy) | +158,046 | 3,047,312 | ||
| 2026-01-12 | BRYNJELSEN SEAN President & CEO | Grant or award · Restricted Stock Units | +100,517 | 3,147,829 | ||
| 2026-01-12 | Krempa David Chief Business Officer | Grant or award · Employee Stock Option (Right to Buy) | +40,655 | 670,893 | ||
| 2026-01-12 | Krempa David Chief Business Officer | Grant or award · Restricted Stock Units | +25,856 | 696,749 | ||
| 2026-01-12 | Gruber James R. Chief Financial Officer | Grant or award · Employee Stock Option (Right to Buy) | +40,655 | 254,075 | ||
| 2026-01-12 | Gruber James R. Chief Financial Officer | Grant or award · Restricted Stock Units | +25,856 | 279,931 | ||
| 2026-01-01 | BRYNJELSEN SEAN President & CEO | Shares withheld for taxes | −5,015 | $15.39 | $77K | 2,889,266 |
| 2025-12-12 | Erdogan-Trinkaus Ipek Chief Commercial Officer | Shares withheld for taxes | −85 | $16.90 | $1K | 2,403 |
| 2025-12-12 | Krempa David Chief Business Officer | Shares withheld for taxes | −6,264 | $17.00 | $106K | 632,180 |
| 2025-12-12 | Gruber James R. Chief Financial Officer | Shares withheld for taxes | −4,542 | $16.99 | $77K | 215,713 |
| 2025-12-12 | BRYNJELSEN SEAN President & CEO | Shares withheld for taxes | −6,732 | $16.83 | $113K | 2,894,281 |
| 2025-12-11 | Krempa David Chief Business Officer | Grant or award · Restricted Stock Units | +5,300 | 638,468 | ||
| 2025-12-11 | Gruber James R. Chief Financial Officer | Grant or award · Restricted Stock Units | +5,502 | 210,255 | ||
| 2025-08-20 | Gruber James R. Chief Financial Officer | Sale | −2,631 | $16.02 | $42K | 204,753 |
| 2025-08-19 | Gruber James R. Chief Financial Officer | Sale | −39,082 | $16.16 | $632K | 205,299 |
| 2025-06-16 | Krempa David Chief Business Officer | Sale | −10,223 | $14.73 | $151K | 612,646 |
| 2025-06-13 | Krempa David Chief Business Officer | Sale | −6,800 | $14.77 | $100K | 622,869 |
| 2025-06-12 | Krempa David Chief Business Officer | Sale | −16,977 | $14.92 | $253K | 629,669 |
| 2025-06-10 | Opaleye Management Inc. 10% owner | Purchase | +5,000 | $15.82 | $79K | 2,770,000 |
Page 6 of 13 · 249 trades